{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:59:30Z","timestamp":1790809170547,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":61,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007115.pub2","type":"reference-entry","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T18:46:57Z","timestamp":1256150817000},"source":"Crossref","is-referenced-by-count":101,"title":["Duloxetine for treating painful neuropathy or chronic pain"],"prefix":"10.1002","author":[{"given":"Michael PT","family":"Lunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard AC","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD007115.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/art.20485","article-title":"A double-blind multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder","volume":"50","author":"Arnold","year":"2004","journal-title":"Arthritis and Rheumatism"},{"issue":"1-3","key":"10.1002\/14651858.CD007115.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A randomized double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007115.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD007115.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","article-title":"A double-blind randomized multicentre trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain","volume":"6","author":"Raskin","year":"2005","journal-title":"Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007115.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","article-title":"Efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month randomized double-blind placebo-controlled fixed-dose trial","volume":"136","author":"Russell","year":"2008","journal-title":"Pain"},{"issue":"8","key":"10.1002\/14651858.CD007115.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","article-title":"A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain","volume":"67","author":"Wernicke","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD007115.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpsychires.2004.04.011","article-title":"Duloxetine 60mg once daily in the treatment of painful physical symptoms in patients with major depressive disorder","volume":"39","author":"Brannan","year":"2005","journal-title":"Journal of Psychiatric Research"},{"issue":"4","key":"10.1002\/14651858.CD007115.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.jcp.0000132448.65972.d9","article-title":"Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetine","volume":"24","author":"Goldstein","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007115.pub2-BIB9|cit9","series-title":"EFNS proceedings abstract","article-title":"Duloxetine in the treatment of diabetic peripheral neuropathic pain - results from three clinical trials","author":"Raskin"},{"issue":"1","key":"10.1002\/14651858.CD007115.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jpm.2006.9.29","article-title":"Duloxetine versus routine care in the long-term management of diabetic neuropathic pain","volume":"9","author":"Raskin","year":"2006","journal-title":"Journal of Palliative Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007115.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1526-4637.2006.00207.x","article-title":"Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study","volume":"7","author":"Raskin","year":"2006","journal-title":"Pain Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007115.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ncpneuro0091","article-title":"Does duloxetine safely and affectively reduce the severity of diabetic peripheral neuropathic pain?","volume":"2","author":"Russell","year":"2006","journal-title":"Nature Clinical Practice Neurology"},{"issue":"5","key":"10.1002\/14651858.CD007115.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.curtheres.2006.10.001","article-title":"Duloxetine in the long-term management of diabetic neuropathic pain: an open-label, 52-week extension of a randomized controlled clinical trial","volume":"67","author":"Wernicke","year":"2006","journal-title":"Current Therapeutic Research"},{"issue":"6","key":"10.1002\/14651858.CD007115.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpain.2006.01.443","article-title":"Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain","volume":"7","author":"Wu","year":"2006","journal-title":"The Journal of Pain"},{"key":"10.1002\/14651858.CD007115.pub2-BIB15|cit15","first-page":"568","article-title":"Effects of duloxetin and amitriptilin in neuropathic pain: Study in 180 patients","volume":"8","author":"Canovas","year":"2007","journal-title":"Revista de la Sociedad Espanola del Dolor"},{"issue":"Supplement 3","key":"10.1002\/14651858.CD007115.pub2-BIB16|cit16","first-page":"320","article-title":"Efficacy of duloxetine in low back pain","volume":"15","author":"Skljarevski","year":"2008","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD007115.pub2-BIB17|cit17","unstructured":"Abbott Safety and efficacy study in subjects with diabetic neuropathic pain (NCT00507936) www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD007115.pub2-BIB18|cit18","unstructured":"Adolor Corporation A phase 2a, randomized, double-blind, placebo- and active-controlled, parallel-group, multicenter study to assess the safety and efficacy of ADL5859 100 mg BID in subjects with neuropathic pain associated with diabetic peripheral neuropathy (NCT00603265) www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD007115.pub2-BIB19|cit19","unstructured":"Baylor College of Medicine Open label study of duloxetine for the treatment of phantom limb pain (NCT00425230) www.clinicaltrials.org"},{"key":"10.1002\/14651858.CD007115.pub2-BIB20|cit20","unstructured":"Eli Lilly Company Tolerability of switching to duloxetine for the management of diabetic nerve pain (NCT00266643) www.clinicaltrials.gov 2005"},{"key":"10.1002\/14651858.CD007115.pub2-BIB21|cit21","unstructured":"Eli Lilly Company Duloxetine versus placebo in the treatment of patients with diabetic peripheral neuropathic pain in China (NCT00408993) www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD007115.pub2-BIB22|cit22","unstructured":"Eli Lilly Company Maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain (DPNP) (NCT00322621) www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD007115.pub2-BIB23|cit23","unstructured":"Eli Lilly Company A study of duloxetine in the treatment of fibromyalgia (NCT00125892) www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD007115.pub2-BIB24|cit24","unstructured":"Eli Lilly Company A study for the treatment of painful diabetic neuropathy (NCT00552175) www.clinicaltrials.gov"},{"key":"10.1002\/14651858.CD007115.pub2-BIB25|cit25","unstructured":"Eli Lilly An open-label comparison of duloxetine to other alternatives for the management of diabetic peripheral neuropathic pain (NCT00385671) www.clinicaltrials.gov 2008"},{"key":"10.1002\/14651858.CD007115.pub2-BIB26|cit26","unstructured":"Eli Lilly Company A study comparing duloxetine and placebo in the treatment of fibromyalgia (NCT00673452) www.clinicaltrials.gov"},{"key":"10.1002\/14651858.CD007115.pub2-BIB27|cit27","unstructured":"Eli Lilly Company A long-term study for the treatment of painful diabetic neuropathy (NCT00641719) www.clinicaltrials.gov 2008"},{"key":"10.1002\/14651858.CD007115.pub2-BIB28|cit28","unstructured":"Germans Trias i Pujol Hospital FUNDACI\u00d3 LLUITA CONTRA LA SIDA Pilot, opened, randomized clinical trial to assess the efficacy of duloxetine in the treatment of fibromialgy in patients with infection by HIV 1+ ( NCT00552682) www.clinicaltrials.gov 2008"},{"key":"10.1002\/14651858.CD007115.pub2-BIB29|cit29","unstructured":"University of Surrey A double-blind, randomised, parallel groups investigation into the effects of pregabalin, duloxetine and amitriptyline on aspects of pain, sleep, and next day performance in patients suffering from diabetic peripheral neuropathy www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD007115.pub2-BIB30|cit30","unstructured":"Wake Forest University Three way interaction between gabapentin, duloxetine, and donepezil in patients with diabetic neuropathy www.clinicaltrials.gov 2008"},{"key":"10.1002\/14651858.CD007115.pub2-BIB31|cit31","volume-title":"Meyler's side effects of drugs","author":"Aronson","year":"2006"},{"key":"10.1002\/14651858.CD007115.pub2-BIB32|cit32","first-page":"23","article-title":"Chapter 2 Antidepressant Drugs","volume-title":"Side Effects of Drugs","volume":"29","author":"Aronson","year":"2007"},{"key":"10.1002\/14651858.CD007115.pub2-BIB33|cit33","first-page":"19","article-title":"Chapter 2 Antidepressant Drugs","volume-title":"Side Effects of Drugs","volume":"30","author":"Aronson","year":"2008"},{"issue":"11","key":"10.1002\/14651858.CD007115.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD007115.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1185\/030079908X253852","article-title":"Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK","volume":"24","author":"Beard","year":"2008","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"10.1002\/14651858.CD007115.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"European Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD007115.pub2-BIB37|cit37","first-page":"728","article-title":"The fibromyalgia impact questionnaire: development and validation","volume":"18","author":"Burckhardt","year":"1991","journal-title":"Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD007115.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD007115.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2174\/1381612053764805","article-title":"The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression","volume":"11","author":"Bymaster","year":"2005","journal-title":"Current Pharmaceutical Design"},{"issue":"7","key":"10.1002\/14651858.CD007115.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ncprheum0221","article-title":"Therapy Insight: fibromyalgia - a different type of pain needing a different type of treatment","volume":"2","author":"Dadabhoy","year":"2006","journal-title":"Nature Clinical Practice Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD007115.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1464-5491.2004.01271.x","article-title":"Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes","volume":"21","author":"Daousi","year":"2004","journal-title":"Diabetic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007115.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/dtb.2007.45429","article-title":"Is there a place for duloxetine?","volume":"45","author":"Anon","year":"2007","journal-title":"Drug and Therapeutic Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD007115.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD007115.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD007115.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4088\/JCP.v65n0411","article-title":"The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?","volume":"65","author":"Fava","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007115.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1185\/030079906X162719","article-title":"A retrospective polled analysis of duloxetine safety in 23,983 subjects","volume":"23","author":"Gahimer","year":"2007","journal-title":"Current Medical Research Opinion"},{"issue":"1","key":"10.1002\/14651858.CD007115.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2217\/1745509X.2.1.135","article-title":"Adjunctive Pahramacological management of persistent, nonmalignant pain in older individuals","volume":"2","author":"Guay","year":"2006","journal-title":"Aging Health"},{"issue":"1-2","key":"10.1002\/14651858.CD007115.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2006.01.030","article-title":"Epidemiology and treatment of neuropathic pain: the UK primary care perspective","volume":"122","author":"Hall","year":"2006","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007115.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/9780470712184.ch8","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"Supplement","key":"10.1002\/14651858.CD007115.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.clinthera.2007.12.002","article-title":"Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies","volume":"29","author":"Kajdasz","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD007115.pub2-BIB51|cit51","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004742.pub2","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults","author":"Mariappan","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007115.pub2-BIB52|cit52","first-page":"51","article-title":"Definitions and Classification of Pain","volume-title":"Principles and practice of pain management","author":"Nagda","year":"2004"},{"issue":"2. DOI:10.1002\/","key":"10.1002\/14651858.CD007115.pub2-BIB53|cit53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006533","article-title":"Duloxetine versus other anti-depressive agents for depression","author":"Nose","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007115.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2165\/0019053-200826120-00007","article-title":"A cost-utility comparison of four first-line medications in painful diabetic neuropathy","volume":"26","author":"O'Connor","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1002\/14651858.CD007115.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.yic.0000224782.83287.3c","article-title":"Efficacy of duloxetine in painful symptoms: analgesic or antidepressant effect?","volume":"21","author":"Perahia","year":"2006","journal-title":"International Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD007115.pub2-BIB56|cit56","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005454.pub2","article-title":"Antidepressants for neuropathic pain","author":"Saarto","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007115.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1471-0528.2006.00877.x","article-title":"What do we know about duloxetine's mode of action? Evidence from animals to humans","volume":"113 Suppl 1","author":"Scheussler","year":"2006","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"Aug 1","key":"10.1002\/14651858.CD007115.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.","volume":"8","author":"Sultan","year":"2008","journal-title":"Biomed Central Neurology"},{"issue":"18","key":"10.1002\/14651858.CD007115.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: Redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD007115.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002018-200730050-00007","article-title":"An evaluation of the cardiovascular safety profile of duloxetine","volume":"30","author":"Wernicke","year":"2007","journal-title":"Drug Safety"},{"issue":"3. Art No.:CD00","key":"10.1002\/14651858.CD007115.pub2-BIB61|cit61","article-title":"Gabapentin for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007115.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T00:00:00Z","timestamp":1388707200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007115.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T18:32:12Z","timestamp":1634063532000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007115.pub2"}},"subtitle":[],"editor":[{"given":"Michael PT","family":"Lunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":61,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007115.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007115.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,10,7]]}}}